Patrick J Heron - Net Worth and Insider Trading
Patrick J Heron Net Worth
The estimated net worth of Patrick J Heron is at least $514 Million dollars as of 2024-06-15. Patrick J Heron is the Director of Vaxcyte Inc and owns about 2,309,554 shares of Vaxcyte Inc (PCVX) stock worth over $168 Million. Patrick J Heron is the Director of Imago BioSciences Inc and owns about 2,971,274 shares of Imago BioSciences Inc (IMGO) stock worth over $107 Million. Patrick J Heron is also the Director of Mirum Pharmaceuticals Inc and owns about 3,728,875 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $97 Million. Besides these, Patrick J Heron also holds Arcutis Biotherapeutics Inc (ARQT) , Collegium Pharmaceutical Inc (COLL) , Passage Bio Inc (PASG) , Cidara Therapeutics Inc (CDTX) , Iterum Therapeutics PLC (ITRM) . Details can be seen in Patrick J Heron's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Patrick J Heron has not made any transactions after 2024-03-04 and currently still holds the listed stock(s).
Transaction Summary of Patrick J Heron
Patrick J Heron Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patrick J Heron owns 20 companies in total, including Tarsus Pharmaceuticals Inc (TARS) , Iterum Therapeutics PLC (ITRM) , and Vaxcyte Inc (PCVX) among others .
Click here to see the complete history of Patrick J Heron’s form 4 insider trades.
Insider Ownership Summary of Patrick J Heron
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TARS | Tarsus Pharmaceuticals Inc | 2020-10-15 | 10 percent owner |
ITRM | Iterum Therapeutics PLC | 2019-05-24 | director & 10 percent owner |
PCVX | Vaxcyte Inc | 2020-06-16 | director |
2019-10-24 | 10 percent owner | ||
2023-11-09 | director & 10 percent owner | ||
2020-03-03 | director & 10 percent owner | ||
2024-03-04 | director & 10 percent owner | ||
2018-09-25 | 10 percent owner | ||
2017-07-24 | 10 percent owner | ||
2018-06-20 | 10 percent owner | ||
2017-01-25 | 10 percent owner | ||
2017-02-14 | 10 percent owner | ||
2016-11-01 | director | ||
2015-05-12 | director & 10 percent owner | ||
2015-06-24 | 10 percent owner | ||
2015-04-20 | director | ||
2021-07-20 | director | ||
2020-12-08 | director | ||
2022-04-28 | director & 10 percent owner | ||
2020-12-08 | director |
Patrick J Heron Latest Holdings Summary
Patrick J Heron currently owns a total of 8 stocks. Among these stocks, Patrick J Heron owns 2,309,554 shares of Vaxcyte Inc (PCVX) as of June 16, 2020, with a value of $168 Million and a weighting of 32.79%. Patrick J Heron owns 2,971,274 shares of Imago BioSciences Inc (IMGO) as of July 20, 2021, with a value of $107 Million and a weighting of 20.83%. Patrick J Heron also owns 3,728,875 shares of Mirum Pharmaceuticals Inc (MIRM) as of November 9, 2023, with a value of $97 Million and a weighting of 18.81%. The other 5 stocks Arcutis Biotherapeutics Inc (ARQT) , Collegium Pharmaceutical Inc (COLL) , Passage Bio Inc (PASG) , Cidara Therapeutics Inc (CDTX) , Iterum Therapeutics PLC (ITRM) have a combined weighting of 27.57% among all his current holdings.
Latest Holdings of Patrick J Heron
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PCVX | Vaxcyte Inc | 2020-06-16 | 2,309,554 | 72.94 | 168,458,869 |
IMGO | Imago BioSciences Inc | 2021-07-20 | 2,971,274 | 36.01 | 106,995,577 |
MIRM | Mirum Pharmaceuticals Inc | 2023-11-09 | 3,728,875 | 25.92 | 96,652,440 |
ARQT | Arcutis Biotherapeutics Inc | 2024-03-04 | 8,817,666 | 8.63 | 76,096,458 |
COLL | Collegium Pharmaceutical Inc | 2015-05-12 | 1,887,332 | 31.76 | 59,941,664 |
PASG | Passage Bio Inc | 2020-03-03 | 5,009,219 | 1.05 | 5,259,680 |
CDTX | Cidara Therapeutics Inc | 2015-04-20 | 14,551 | 13.44 | 195,565 |
ITRM | Iterum Therapeutics PLC | 2018-05-30 | 102,554 | 1.15 | 117,937 |
Holding Weightings of Patrick J Heron
Patrick J Heron Form 4 Trading Tracker
According to the SEC Form 4 filings, Patrick J Heron has made a total of 1 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vaxcyte Inc is the acquisition of 250,000 shares on June 16, 2020, which cost Patrick J Heron around $4 Million.
According to the SEC Form 4 filings, Patrick J Heron has made a total of 1 transactions in Imago BioSciences Inc (IMGO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Imago BioSciences Inc is the acquisition of 187,500 shares on July 20, 2021, which cost Patrick J Heron around $3 Million.
According to the SEC Form 4 filings, Patrick J Heron has made a total of 5 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 2,910 shares on November 9, 2023, which cost Patrick J Heron around $82,353.
More details on Patrick J Heron's insider transactions can be found in the Insider Trading History of Patrick J Heron table.Insider Trading History of Patrick J Heron
- 1
Patrick J Heron Trading Performance
GuruFocus tracks the stock performance after each of Patrick J Heron's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick J Heron is 8.38%. GuruFocus also compares Patrick J Heron's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick J Heron within 3 months outperforms 8 times out of 13 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Patrick J Heron's insider trading performs compared to the benchmark.
Performance of Patrick J Heron
Patrick J Heron Ownership Network
Ownership Network List of Patrick J Heron
Ownership Network Relation of Patrick J Heron
Patrick J Heron Owned Company Details
What does Tarsus Pharmaceuticals Inc do?
Who are the key executives at Tarsus Pharmaceuticals Inc?
Patrick J Heron is the 10 percent owner of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include Chief Human Resources Officer Dianne C. Whitfield , General Counsel Bryan Wahl , and Chief Operating Officer Seshadri Neervannan .
Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary
Over the past 18 months, Patrick J Heron made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 323,447 shares made by Bobak R. Azamian , a net sale of 14,020 shares made by Aziz Mottiwala , and a net sale of 21,966 shares made by Leonard M. Greenstein .
In summary, during the past 3 months, insiders sold 28,810 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 28,810 shares. During the past 18 months, 403,563 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 393,057 shares.
Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tarsus Pharmaceuticals Inc Insider Transactions
Patrick J Heron Mailing Address
Above is the net worth, insider trading, and ownership report for Patrick J Heron. You might contact Patrick J Heron via mailing address: 550 Hamilton Ave., Suite 100, Palo Alto Ca 94301.